A comparison of the antifungal properties of onion (Allium cepa), ginger (Zingiber officinale) and garlic (Allium sativum) against Aspergillus flavus, Aspergillus niger and Cladosporium herbarum

Research Journal of Medicinal Plant

Volumn 5, Issue 3, 2011, Pages 281-287

  Tagoe, D N A ^a,b   Nyarko, H D ^a   Akpaka, R ^a  

^a UNIVERSITY OF CAPE COAST   (Ghana)

^b Medical Laboratory Section   (Ghana)

Author keywords

Antifungal activity; Antimicrobial activity; Fungi; Growth diameter; Plant extracts; Potato dextrose agar

Indexed keywords

ALCOHOL; ANTIFUNGAL AGENT; GARLIC EXTRACT; GINGER EXTRACT; GLUCOSE; ONION EXTRACT;

AGAR MEDIUM; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; BIOFILTRATION; CLADOSPORIUM; CLADOSPORIUM HERBARUM; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FUNGAL COLONIZATION; FUNGUS GROWTH; FUNGUS ISOLATION; GROWTH INHIBITION; GROWTH REGULATION; INCUBATION TIME; LIQUID PHASE MICROEXTRACTION; MICROBIAL ACTIVITY; NONHUMAN;

ALLIUM CEPA; ALLIUM SATIVUM; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; DAVIDIELLA TASSIANA; FUNGI; SOLANUM TUBEROSUM; ZINGIBER OFFICINALE;

EID: 77957151637     PISSN: 18193455     EISSN: 21517924     Source Type: Journal    
DOI: 10.3923/rjmp.2011.281.287     Document Type: Article

References (29)

1. Adetumbi, M.A., G.T. Javor and B.H. Lau, 1986. Allium sativum (garlic) inhibits lipid synthesis by Candida albicans. Antimicrob. Agents Chemother., 30: 499-501.
2. Alam, S., A. Nargis, M. Ferdousi Begum, M. Sabina Banu and M. Rafiqul Islam, 2002. Antifungal activities in vitro of some plant extracts and smoke on four fungal pathogens of different hosts. Pak. J. Biol. Sci., 5: 307-309.
3. Azu, N.C. and R.A. Onyeagba, 2007. Antimicrobial properties of extracts of Allium cepa (onions) and Zingiber officinale (ginger) on Escherichia coli, Salmonella typhi and Bacillus subtilis. Internet J. Trop. Med.,
4. Azzouz, M.A. and L.R. Bullerman, 1982. Comparative antimycotic effects of selected herbs and spices, plant components and commercial antifungal agents. J. Food Protect., 45: 1248-1301.
5. Brakhage, A.A., 2005. Systemic fungal infections caused by Aspergillus species: Epidemiology, infection process and virulence determinants. Curr. Drug Targets, 6: 875-886.
6. Bullerman, L.B., 1974. Inhibition of aflatoxin production by cinnamon. J. Food Sci., 39: 1163-1165.
7. Bullerman, L.B., F.Y. Lieu and S.A. Seier, 1977. Inhibition of growth and aflatoxin production by cinnamon and clove oils, cinnamic aldehyde and eugenol. J. Food Sci., 42: 1107-1109.
8. Cavallito, C.J. and J.H. Bailey, 1944. Allicin, the antibacterial principle of Allium sativum. Isolation, physical properties and antibacterial action. J. Am. Chem. Soc., 66: 1950-1951.
9. Chrubasik, S., M.H. Pittler and B.D. Roufogalis, 2005. Zingiberis rhizome: Comprehensive review on the ginger effect and efficacy profiles. Phytomedicine, 12: 684-701.
10. Dankert, J., T.F. Tromp, H. De Vries and H.J. Klasen, 1979. Antimicrobial activity of crude juices of Allium ascalonicum, Allium cepa and Allium sativum. Zentralbl. Bakteriol., 245: 229-239.
11. Grzanna, R., L. Lindmark and C.G. Frondoza, 2005. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food., 8: 125-132.
12. Habtemarian, S., A.I. Gray and P.G. Waterman, 1993. A new antibacterial sesquiterpene from Premma oligotrichia. J. Nat. Prod., 56: 140-143.
13. Hasan, M.M., S.P. Chowdhury, S. Alam, B. Hossain and M.S. Alam, 2005. Antifungal effects of plant extracts on seed-borne fungi of wheat seed regarding seed germination, Seedling health and vigour index. Pak. J. Biol. Sci., 8: 1284-1289.
14. Hibert, S., 2006. Medicinal properties of ginger, http://www.jamaica-gleaner.com/gleaner/20061012/eyes/eyes1.html.
15. Hube, B., 2004. From commensal to pathogen: Stage-and tissue-specific gene expression of Candida albicans. Curr. Opinion Microbiol., 7: 336-341.
16. Kim, E., J. Min, T. Kim, S. Lee and H. Yang et al., 2005. Gingerol, a pungent ingredient of ginger inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun., 335: 300-308.
17. Moss, S.T., 1986. The Biology of Marine Fungi. Cambridge University Press, Cambridge, UK., ISBN: 0-521-30899-2, pp: 76.
18. Nielsen, K. and J. Heitman, 2007. Sex and virulence of human pathogenic fungi. Adv. Genet., 57: 143-173.
19. Peraica, M., B. Radic, A. Lucic and M. Pavlovic, 1999. Toxic effects of mycotoxins in humans. Bull. World Health Org, 77: 754-766.
20. Rocio, M.C. and J.L. Rion, 1982. A review of some antimicrobial substances isolated from medicinal plants reported in literature 1978-1972. Phytoether. Rev, 3: 117-125.
21. Samson, R.A., J. Houbraken, R.C. Summerbell, B. Flannigan and J.D. Miller, 2001. Common and Important Species of Fungi and Actinomycetes in Indoor Environments. In: Microogranisms in Home and Indoor Work Environments, Flannigan, B., R.A. Samson and J.D. Miller (Eds.). Taylor and Francis, New York, pp: 287-292.
22. Samson, R.A., J.A.M.P. Houbraken, A.F.A. Kuijpers, J.M. Frank and J.C. Frisvad, 2004. New ochratoxin A or sclerotium producing species in Aspergillus section Nigri. Stud. Mycol, 50: 45-46.
23. Schuster, E., N. Dunn-Coleman, J.C. Frisvad and P.W. van Dijck, 2002. On the safety of Aspergillus niger. A review. Applied Microbiol. Biotechnol, 59: 426-435.
24. Sharma, A., G.M. Tewari, A.J. Shrikhande, S.R. Padwal-Desai and C. Bandyopdhyay, 1979. Inhibition of aflatoxin producing fungi by onion extracts. J. Food Sci, 44: 1545-1547.
25. Sims, J., 2001. Gale Encyclopedia of Alternative Medicine. Thomson Gale, New Hampshire.
26. Vermani, K. and S. Garg, 2002. Herbal medicine for sexually transmitted disease and AIDS. J. Ethnopharmacol, 80: 49-66.
27. Weber, N.D., D.O. Anderson, J.A. North, B.K. Murray, L.D. Lawson and B.G. Huger, 1992. In vitro vinicidal activity of Allium sativum (Garlic) extracts and compounds. Plant. Med, 58: 417-423.
28. Winston, C., 2008. Onions are beneficial for your health, http://geniuscook.com/onions/.
29. Wood, C.D., 1988. Comparison of efficacy of ginger with various antimicrobial sickness drugs. Clin. Res. Practices Drug Regul. Affairs, 6: 129-136.